VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13 | +30.0% | 16,070 | -2.4% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 16,470 | -2.1% | 0.00% | – |
| Q3 2022 | $20,000 | -28.6% | 16,820 | 0.0% | 0.00% | – |
| Q2 2022 | $28,000 | -26.3% | 16,820 | -2.0% | 0.00% | – |
| Q1 2022 | $38,000 | -37.7% | 17,170 | -3.4% | 0.00% | – |
| Q4 2021 | $61,000 | -34.4% | 17,770 | -8.5% | 0.00% | – |
| Q3 2021 | $93,000 | – | 19,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 988,165 | $614,935 | 0.54% |
| Quantum Private Wealth, LLC | 10,000 | $6,223 | 0.00% |
| Warberg Asset Management LLC | 17,012 | $10,561 | 0.00% |
| Belpointe Asset Management LLC | 19,045 | $11,852 | 0.00% |
| OSAIC HOLDINGS, INC. | 600 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $62,744 | 0.00% |
| WELLS FARGO & COMPANY/MN | 59 | $37 | 0.00% |
| NORTHERN TRUST CORP | 15,221 | $9,472 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 66,038 | $41 | 0.00% |